Utilidad de la determinación cualitativa de troponina I y creatinfosfocinasa isoenzima MB en los síndromes isquémicos coronarios agudos

Meraz Soria, Carlos Alberto; Camarena Alejo, Gilberto; Elizalde González, José Javier; Sánchez, Janet Aguirre; Martínez Sánchez, Jesús.
Arch. cardiol. Méx ; 76(1): 37-46, ene.-mar. 2006.
Artículo en Español | LILACS | ID: lil-569529

Documentos relacionados

  1. [Usefulness of rapid bedside assay of cardiac troponin I and creatine phosphokinase-MB in acute ischemic coronary syndromes].
  2. [Changes of plasma cardiotrophin-1 levels in neonates with myocardial ischemic injury].
  3. Neutrophil-to-lymphocyte Ratio and Its Relation with Markers of Inflammation and Myocardial Necrosis in Patients with Acute Coronary Syndrome.
  4. Performance Evaluation of the FREND Cardiac Triple Cartridge on the FREND System.
  5. [Qualitative determination of markers for myocardiac necrosis during pre-hospital admission for acute coronary syndrome].
  6. Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein
  7. Assessment of cardiac parameters after the administration of nicorandil before primary percutaneous coronary intervention.
  8. Extracellular ubiquitin levels are increased in coronary heart disease and associated with the severity of the disease.
  9. A pilot randomized trial of pentoxifylline for the reduction of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
  10. [Multiplex analysis on the luminex platform in complex estimation of cardiovascular biomarker dynamics in patients with acute myocardial infarction.]